RiverFront Investment Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

RiverFront Investment Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-105,013	Closed	-$11.9M	–	60
2015 Q4	$11.9M	Sell	105,013 -4,373	-4%	-$471K	0.34%	44
2015 Q3	$11.1M	Buy	109,386 +1,683	+2%	+$200K	0.32%	40
2015 Q2	$13.4M	Buy	107,703 +5,977	+6%	+$721K	0.37%	43
2015 Q1	$12M	Buy	101,726 +345	+0.3%	+$39K	0.34%	38
2014 Q4	$10.3M	Sell	101,381 -38,966	-28%	-$3.81M	0.31%	42
2014 Q3	$12.9M	Sell	140,347 -263,034	-65%	-$22.8M	0.32%	48
2014 Q2	$33.2M	Buy	+403,381	New	+$30.8M	0.82%	34

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RiverFront Investment Group's FBT Position: Q1 2016 in Review

RiverFront Investment Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 105,013 shares — an estimated $11.9M sold.

RiverFront Investment Group first reported a position in FBT in Q2 2014 and held it in 7 quarters. The position peaked at $33.2M in Q2 2014. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

RiverFront Investment Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
RiverFront Investment Group sold 105,013 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $11.9M.
RiverFront Investment Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and held it in 7 quarters.
RiverFront Investment Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $33.2M in Q2 2014.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on RiverFront Investment Group's 13F filing for Q1 2016, filed 9 May 2016.